TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request September 23, 1983